TrialThe pharmacogenomics journal2002

The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists.

D C Shields et al.PubMed ↗Publisher ↗

No numbers read from the abstract.